InvestorsHub Logo
Followers 19
Posts 539
Boards Moderated 0
Alias Born 07/25/2014

Re: empiricalONE post# 7347

Friday, 02/22/2019 11:32:31 PM

Friday, February 22, 2019 11:32:31 PM

Post# of 35961
To carry on another point I made in the post I am replying to, one of the major catalysts here is, of course, the potential for a buyout. I will not comment on the likelihood of such an event, it is clearly WILD SPECULATION and I would just like to make a hypothetical point here. I spoke of the inherent value remaining in the rights of the drug. It cost 100 million to bring this through phase 2. Any HYPOTHETICAL discussion of a buyout would automatically be in excess of this 100 million, it's just common sense. Chevy doesn't spend $15,000 to build a car, and then turn around and sell it on the lot for $10,000. So it is with this drug (I personally think it would be a foolish business decision to sell this off) it is worth much more wholly as your own.

This value can be likened to a savings bond. We know it has worth, but we must be patient until it is fully mature. We cannot realize its full value in present time, but we ought to have some admission that the value is indeed there.